Circulation. Cardiovascular Interventions
-
Publication Venue For
-
Safety and Effectiveness of the SVELTE Fixed-Wire and Rapid Exchange Bioresorbable-Polymer Sirolimus-Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions: Results of the OPTIMIZE Randomized Study..
14:e010609.
2021
-
Incidence and Clinical Significance of Worsening Tricuspid Regurgitation Following Surgical or Transcatheter Aortic Valve Replacement: Analysis From the PARTNER IIA Trial..
14:e010437.
2021
-
Ankle-Brachial Index for Risk Stratification in Patients With Symptomatic Peripheral Artery Disease With and Without Prior Lower Extremity Revascularization: Observations From the EUCLID Trial..
14:e009871.
2021
-
Coronary Artery Disease Evaluation and Management Considerations for High Risk Occupations: Commercial Vehicle Drivers and Pilots..
14:e009950.
2021
-
Five-Year Clinical and Quality of Life Outcomes From the CoreValve US Pivotal Extreme Risk Trial..
14:e010258.
2021
-
Variation in Antithrombotic Therapy and Clinical Outcomes in Patients With Preexisting Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry..
14:e009963.
2021
-
Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent..
14:e010144.
2021
-
Therapeutic Approaches for the No-Option Refractory Angina Patient..
14:e009002.
2021
-
Time Delay, Infarct Size, and Microvascular Obstruction After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction..
14:e009879.
2021
-
Antithrombotic Regimens in Low-Risk Patients Undergoing Transcatheter Aortic Valve Replacement: Trials Evaluating Patient-Centered Outcomes Needed..
14:e010331.
2021
-
Is Transcatheter Aortic Valve Replacement Worth the Wait?.
13:e010138.
2020
-
Association of Disease Progression With Cardiovascular and Limb Outcomes in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial..
13:e009326.
2020
-
Use of Natural Language Processing to Improve Identification of Patients With Peripheral Artery Disease..
13:e009447.
2020
-
Teaching Old Treatments New Tricks..
13:e009725.
2020
-
Intensive Training and Real-Time Quality Control by a Physiology Core Laboratory: Lessons From DEFINE-PCI..
13:e009077.
2020
-
Outcome of Flow-Gradient Patterns of Aortic Stenosis After Aortic Valve Replacement: An Analysis of the PARTNER 2 Trial and Registry..
13:e008792.
2020
-
Postprocedural Antithrombotic Therapy Following Left Atrial Appendage Occlusion: No Longer Adrift in Uncertainty?.
13:e009534.
2020
-
Differential Use and Impact of Bleeding Avoidance Strategies on Percutaneous Coronary Intervention-Related Bleeding Stratified by Predicted Risk..
13:e008702.
2020
-
Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice: An Analysis of the ORBIT II Registry..
13:e008274.
2020
-
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention: The PARIS Registry..
13:e008226.
2020
-
Global Approach to High Bleeding Risk Patients With Polymer-Free Drug-Coated Coronary Stents: The LF II Study..
13:e008603.
2020
-
Response by Latif et al to Letter Regarding Article, "Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial"..
13:e009174.
2020
-
Proficiency Divide: A Warning for the Future of Interventional Cardiology..
13:e009013.
2020
-
Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial..
13:e008494.
2020
-
Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: Results From the EXSCEL Trial..
12:e008018.
2019
-
Impact of Procedural Bleeding in Peripheral Artery Disease: An Analysis From EUCLID Trial..
12:e008069.
2019
-
Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction in Clinical Practice: Insights From the Vital Heart Response Registry..
12:e008059.
2019
-
Atrial Fibrillation and Percutaneous Coronary Intervention..
12:e008269.
2019
-
Examining the Operator Learning Curve for Percutaneous Coronary Intervention of Chronic Total Occlusions..
12:e007877.
2019
-
Central Adjudication Identified Additional and Prognostically Important Myocardial Infarctions in Patients Undergoing Percutaneous Coronary Intervention..
12:e007342.
2019
-
Postoperative Transcatheter Interventions in Children Undergoing Congenital Heart Surgery..
12:e007853.
2019
-
Comparison of Rates of Bleeding and Vascular Complications Before, During, and After Trial Enrollment in the SAFE-PCI Trial for Women..
12:e007086.
2019
-
Identifying the Infarct-Related Artery in Patients With Non-ST-Segment-Elevation Myocardial Infarction..
12:e007305.
2019
-
Use of Medicare Claims to Identify Adverse Clinical Outcomes After Mitral Valve Repair..
12:e007451.
2019
-
Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention..
12:e007133.
2019
-
Outcomes After Transcatheter Mitral Valve Repair in Patients With Renal Disease..
12:e007552.
2019
-
Supporting the Crucible of Peer Review..
12:e007835.
2019
-
Association of Anemia With Outcomes Among ST-Segment-Elevation Myocardial Infarction Patients Receiving Primary Percutaneous Coronary Intervention..
11:e007175.
2018
-
Femoropopliteal In-Stent Restenosis..
11:e007559.
2018
-
Clinical Valve Thrombosis After Valve-in-Valve Transcatheter Aortic Valve Replacement..
11:e007495.
2018
-
Left Bundle Branch Block Before Transcatheter Aortic Valve Replacement..
11:e007361.
2018
-
Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population..
11:e006853.
2018
-
Left Ventricular Support..
11:e007214.
2018
-
The Future of Circulation: Cardiovascular Interventions: Changing, Creating, and Maturing..
11:e007115.
2018
-
Stroke and Cardiovascular Outcomes in Patients With Carotid Disease Undergoing Transcatheter Aortic Valve Replacement..
11:e006322.
2018
-
Taking the Reins on Systems of Care for ST-Segment-Elevation Myocardial Infarction Patients: A Report From the American Heart Association Mission: Lifeline Program..
11:e005706.
2018
-
Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients)..
11:e006144.
2018
-
Anticoagulant Use Among Patients With End-Stage Renal Disease Undergoing Percutaneous Coronary Intervention: An Analysis From the National Cardiovascular Data Registry..
11:e005628.
2018
-
Outcomes of Saphenous Vein Graft Intervention With and Without Embolic Protection Device: A Comprehensive Review and Meta-Analysis..
10.
2017
-
Clinical Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry..
10.
2017
-
Q Waves at Presentation in Patients With ST-Segment-Elevation Myocardial Infarction: An Underappreciated Marker of Risk..
10.
2017
-
Relationships Between Baseline Q Waves, Time From Symptom Onset, and Clinical Outcomes in ST-Segment-Elevation Myocardial Infarction Patients: Insights From the Vital Heart Response Registry..
10.
2017
-
Peripheral Artery Disease and Transcatheter Aortic Valve Replacement Outcomes: A Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Therapy Registry..
10.
2017
-
White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry)..
10.
2017
-
Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock..
10.
2017
-
Sex, Region, and Outcomes After Revascularization..
10.
2017
-
Longitudinal Risk of Adverse Events in Patients With Acute Kidney Injury After Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry..
10.
2017
-
Rapid Desensitization of the Patients With Aspirin Hypersensitivity and Coronary Artery Disease..
10.
2017
-
Association of Rapid Care Process Implementation on Reperfusion Times Across Multiple ST-Segment-Elevation Myocardial Infarction Networks..
10.
2017
-
Hospital Readmission as a Transcatheter Aortic Valve Replacement Performance Measure: Too Soon?.
10.
2017
-
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update..
9.
2016
-
Early Cessation of Adenosine Diphosphate Receptor Inhibitors Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study (Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome)..
9.
2016
-
Blood Transfusion and the Risk of Acute Kidney Injury Among Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention..
9.
2016
-
Relationship of Annular Sizing Using Multidetector Computed Tomographic Imaging and Clinical Outcomes After Self-Expanding CoreValve Transcatheter Aortic Valve Replacement..
9.
2016
-
Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis: Results From the TRACER Angiographic Substudy..
9:e003114.
2016
-
Effectiveness of Arterial Closure Devices for Preventing Complications With Percutaneous Coronary Intervention: An Instrumental Variable Analysis..
9:e003464.
2016
-
Temporal Trends in the Risk Profile of Patients Undergoing Outpatient Percutaneous Coronary Intervention: A Report from the National Cardiovascular Data Registry's CathPCI Registry..
9:e003070.
2016
-
Direct Transfer From the Referring Hospitals to the Catheterization Laboratory to Minimize Reperfusion Delays for Primary Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry..
8:e002477.
2015
-
Repeat Cell Therapy for Refractory Angina: Déjà vu All Over Again?.
8.
2015
-
Cluster-randomized clinical trial examining the impact of platelet function testing on practice: the treatment with adenosine diphosphate receptor inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome prospective open label antiplatelet therapy study..
8:e001712.
2015
-
Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularization..
8:e002314.
2015
-
Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registry..
8:e001683.
2015
-
Surgical versus percutaneous coronary revascularization for multivessel disease in diabetic patients with non-ST-segment-elevation acute coronary syndrome: analysis from the Acute Catheterization and Early Intervention Triage Strategy trial..
8.
2015
-
Nationwide Analysis of Patients With ST-Segment-Elevation Myocardial Infarction Transferred for Primary Percutaneous Intervention: Findings From the American Heart Association Mission: Lifeline Program..
8.
2015
-
Stent Thrombosis and Dual Antiplatelet Therapy Interruption With Everolimus-Eluting Stents: Insights From the Xience V Coronary Stent System Trials..
8.
2015
-
Access and non-access site bleeding after percutaneous coronary intervention and risk of subsequent mortality and major adverse cardiovascular events: systematic review and meta-analysis..
8.
2015
-
Activated clotting time and outcomes during percutaneous coronary intervention for non-ST-segment-elevation myocardial infarction: insights from the FUTURA/OASIS-8 Trial..
8.
2015
-
Three-year outcomes associated with embolic protection in saphenous vein graft intervention: results in 49 325 senior patients in the Medicare-linked National Cardiovascular Data Registry CathPCI Registry..
8:e001403.
2015
-
Eptifibatide in coronary intervention: past time for the next chapter..
8:e002340.
2015
-
Evaluation of renal function before and after percutaneous mitral valve repair..
8.
2015
-
Costs of periprocedural complications in patients treated with transcatheter aortic valve replacement: results from the Placement of Aortic Transcatheter Valve trial..
7:829-836.
2014
-
Relationship of the distance between non-PCI hospitals and primary PCI centers, mode of transport, and reperfusion time among ground and air interhospital transfers using NCDR's ACTION Registry-GWTG: a report from the American Heart Association Mission: Lifeline Program..
7:797-805.
2014
-
In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registry..
7:585-593.
2014
-
Mechanisms by which transradial approach may reduce mortality in ST-segment-elevation myocardial infarction..
7:621-627.
2014
-
Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non-ST-segment-elevation acute coronary syndromes or stable ischemic heart disease: results from the Evaluation of Drug-Eluting Stents and Ischemic Events registry..
7:365-373.
2014
-
Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: propensity-matched analysis from the Acute Catheterization and Urgent Intervention Triage Strategy trial..
7:285-293.
2014
-
Response to letters regarding article, "Risk of acute kidney injury after percutaneous coronary interventions using radial versus femoral vascular access: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium"..
7:421.
2014
-
Letter by Grbel et al regarding article, "administration of a loading dose has no additive effect on platelet aggregation during the switch from ongoing clopidogrel treatment to ticagrelor in patients with acute coronary syndrome"..
7:273.
2014
-
Risk of acute kidney injury after percutaneous coronary interventions using radial versus femoral vascular access: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium..
7:190-198.
2014
-
Angiographic validation of the American College of Cardiology Foundation-the Society of Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization Strategies study..
7:11-18.
2014
-
Neurological injury after transcatheter aortic valve implantation: are the trees falling silently or is our hearing impaired?.
6:599-601.
2013
-
Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A)..
6:604-614.
2013
-
Adoption of transradial percutaneous coronary intervention and outcomes according to center radial volume in the Veterans Affairs Healthcare system: insights from the Veterans Affairs clinical assessment, reporting, and tracking (CART) program..
6:336-346.
2013
-
Antianginal therapy before percutaneous coronary intervention..
6:436-443.
2013
-
Bypassing the emergency department and time to reperfusion in patients with prehospital ST-segment-elevation: findings from the reperfusion in acute myocardial infarction in Carolina Emergency Departments project..
6:399-406.
2013
-
Comparison of bivalirudin and radial access across a spectrum of preprocedural risk of bleeding in percutaneous coronary intervention: analysis from the national cardiovascular data registry..
6:347-353.
2013
-
Percutaneous steerable robotic tool delivery platform and metal microelectromechanical systems device for tissue manipulation and approximation: closure of patent foramen ovale in an animal model..
6:468-475.
2013
-
Intra-aortic balloon pump trials: questions, answers, and unresolved issues..
6:317-321.
2013
-
Stroke after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: timing, characteristics, and clinical outcomes..
6:176-183.
2013
-
Repeat revascularization after PCI: are we reinventing the wheel or redefining Achilles' heel?.
5:746-747.
2012
-
Repeat revascularization after contemporary percutaneous coronary intervention: an evaluation of staged, target lesion, and other unplanned revascularization procedures during the first year..
5:772-782.
2012
-
Mentored simulation training improves procedural skills in cardiac catheterization: a randomized, controlled pilot study..
5:672-679.
2012
-
Transport time and care processes for patients transferred with ST-segment-elevation myocardial infarction: the reperfusion in acute myocardial infarction in Carolina emergency rooms experience..
5:555-562.
2012
-
A randomized, double-blind, active-controlled phase 2 trial to evaluate a novel selective and reversible intravenous and oral P2Y12 inhibitor elinogrel versus clopidogrel in patients undergoing nonurgent percutaneous coronary intervention: the INNOVATE-PCI trial..
5:336-346.
2012
-
Pharmacokinetic and pharmacodynamic effects of elinogrel: results of the platelet function substudy from the intravenous and oral administration of elinogrel to evaluate tolerability and efficacy in nonurgent percutaneous coronary intervention patients (INNOVATE-PCI) trial..
5:347-356.
2012
-
Cardiovascular devices and platelet interactions: understanding the role of injury, flow, and cellular responses..
5:296-304.
2012
-
Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study..
5:261-269.
2012
-
Effect of CYP2C19*2 and *3 loss-of-function alleles on platelet reactivity and adverse clinical events in East Asian acute myocardial infarction survivors treated with clopidogrel and aspirin..
4:585-594.
2011
-
Platelet-mediated thrombosis and drug-eluting stents..
4:629-637.
2011
-
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary..
4:522-534.
2011
-
Bleeding risk comparing targeted low-dose heparin with bivalirudin in patients undergoing percutaneous coronary intervention: results from a propensity score-matched analysis of the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry..
4:463-473.
2011
-
Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry..
4:474-480.
2011
-
Operator radiation exposure during percutaneous coronary procedures through the left or right radial approach: the TALENT dosimetric substudy..
4:226-231.
2011
-
Clinical outcomes in patients with the concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention: an analysis from the Guthrie Health Off-Label Stent (GHOST) investigators..
4:162-170.
2011
-
Further ex vivo evidence supporting higher aspirin dosing in patients with coronary artery disease and diabetes..
4:118-120.
2011
-
A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial..
3:414-422.
2010
-
Clinical and angiographic predictors of short- and long-term ischemic events in acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial..
3:308-316.
2010
-
Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry..
3:327-334.
2010
-
Incidence, predictors, and prognostic implications of hospitalization for late bleeding after percutaneous coronary intervention for patients older than 65 years..
3:140-147.
2010
-
Anticoagulant therapy for percutaneous coronary intervention..
3:80-88.
2010
-
Outcomes for patients with ST-elevation myocardial infarction in hospitals with and without onsite coronary artery bypass graft surgery: the New York State experience..
2:519-527.
2009
-
Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction..
2:366-375.
2009
-
Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry..
2:222-229.
2009
-
The cart and the horse: the advancing technology of carotid artery stenting..
2:153-155.
2009
-
Advancing biomarker science in the 21st century..
2:4-5.
2009
-
Stent parameters predict major adverse clinical events and the response to platelet glycoprotein IIb/IIIa blockade: findings of the ESPRIT trial..
2:43-51.
2009
-
Trends in the association between age and in-hospital mortality after percutaneous coronary intervention: National Cardiovascular Data Registry experience..
2:20-26.
2009